Dishman Pharmaceuticals Acquires UK-based Synprotec

Dishman Pharmaceuticals & Chemicals Ltd has acquired a Manchester-based contract research company, Synprotec Ltd, through its 100 percent wholly owned UK-based subsidiary company Dishman Europe Ltd. Acording to a company release, the assets base of Synprotec (excluding the value of IP and without revaluation of assets) is currently around pound sterling 2 million and the Company has negotiated the cost of acquisition even below this price. The acquisition of Synprotec in the hands of the company will be as a debt-free company.

Pharmabiz (http://www.pharmabiz.com/article/detnews.asp?articleid=27226§ionid=)